UPDATE 1-AstraZeneca pill slashes lung cancer progression in study

* Drug targets genetic mutation common in China, east Asia (Adds AstraZeneca comment, further details)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.